These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 28952612)

  • 1. Patients with Primary Immunodeficiencies Are a Reservoir of Poliovirus and a Risk to Polio Eradication.
    Aghamohammadi A; Abolhassani H; Kutukculer N; Wassilak SG; Pallansch MA; Kluglein S; Quinn J; Sutter RW; Wang X; Sanal O; Latysheva T; Ikinciogullari A; Bernatowska E; Tuzankina IA; Costa-Carvalho BT; Franco JL; Somech R; Karakoc-Aydiner E; Singh S; Bezrodnik L; Espinosa-Rosales FJ; Shcherbina A; Lau YL; Nonoyama S; Modell F; Modell V; ; Barbouche MR; McKinlay MA
    Front Immunol; 2017; 8():685. PubMed ID: 28952612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modeling the prevalence of immunodeficiency-associated long-term vaccine-derived poliovirus excretors and the potential benefits of antiviral drugs.
    Duintjer Tebbens RJ; Pallansch MA; Thompson KM
    BMC Infect Dis; 2015 Sep; 15():379. PubMed ID: 26382043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Update on Vaccine-Derived Polioviruses - Worldwide, January 2014-March 2015.
    Diop OM; Burns CC; Sutter RW; Wassilak SG; Kew OM;
    MMWR Morb Mortal Wkly Rep; 2015 Jun; 64(23):640-6. PubMed ID: 26086635
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New insights into physiopathology of immunodeficiency-associated vaccine-derived poliovirus infection; systematic review of over 5 decades of data.
    Shaghaghi M; Soleyman-Jahi S; Abolhassani H; Yazdani R; Azizi G; Rezaei N; Barbouche MR; McKinlay MA; Aghamohammadi A
    Vaccine; 2018 Mar; 36(13):1711-1719. PubMed ID: 29478755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunodeficiency-related vaccine-derived poliovirus (iVDPV) cases: a systematic review and implications for polio eradication.
    Guo J; Bolivar-Wagers S; Srinivas N; Holubar M; Maldonado Y
    Vaccine; 2015 Mar; 33(10):1235-42. PubMed ID: 25600519
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Poliovirus Excretion in Children with Primary Immunodeficiency Disorders, India.
    Mohanty MC; Madkaikar MR; Desai M; Taur P; Nalavade UP; Sharma DK; Gupta M; Dalvi A; Shabrish S; Kulkarni M; Aluri J; Deshpande JM
    Emerg Infect Dis; 2017 Oct; 23(10):1664-1670. PubMed ID: 28930011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Update on Immunodeficiency-Associated Vaccine-Derived Polioviruses - Worldwide, July 2018-December 2019.
    Macklin G; Diop OM; Humayun A; Shahmahmoodi S; El-Sayed ZA; Triki H; Rey G; Avagyan T; Grabovac V; Jorba J; Farag N; Mach O
    MMWR Morb Mortal Wkly Rep; 2020 Jul; 69(28):913-917. PubMed ID: 32673297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Update on Vaccine-Derived Polioviruses - Worldwide, January 2016-June 2017.
    Jorba J; Diop OM; Iber J; Henderson E; Sutter RW; Wassilak SGF; Burns CC
    MMWR Morb Mortal Wkly Rep; 2017 Nov; 66(43):1185-1191. PubMed ID: 29095803
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neutralization capacity of highly divergent type 2 vaccine-derived polioviruses from immunodeficient patients.
    McDonald SL; Weldon WC; Wei L; Chen Q; Shaw J; Zhao K; Jorba J; Kew OM; Pallansch MA; Burns CC; Steven Oberste M
    Vaccine; 2020 Mar; 38(14):3042-3049. PubMed ID: 32089462
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of Enterovirus Excretion and Identification of VDPVs in Patients with Primary Immunodeficiency in India: Outcome of ICMR-WHO Collaborative Study Phase-I.
    Mohanty MC; Desai M; Mohammad A; Aggarwal A; Govindaraj G; Bhattad S; Lashkari HP; Rajasekhar L; Verma H; Kumar A; Sawant U; Varose SY; Taur P; Yadav RM; Tatkare M; Fernandes M; Bargir U; Majumdar S; Edavazhippurath A; Rangarajan J; Manthri R; Madkaikar MR
    Vaccines (Basel); 2023 Jul; 11(7):. PubMed ID: 37515027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Health Economic Analysis of Antiviral Drugs in the Global Polio Eradication Endgame.
    Badizadegan K; Kalkowska DA; Thompson KM
    Med Decis Making; 2023; 43(7-8):850-862. PubMed ID: 37577803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Poliovirus excretion following vaccination with live poliovirus vaccine in patients with primary immunodeficiency disorders: clinicians' perspectives in the endgame plan for polio eradication.
    Galal NM; Meshaal S; ElHawary R; Nasr E; Bassiouni L; Ashghar H; Farag NH; Mach O; Burns C; Iber J; Chen Q; ElMarsafy A
    BMC Res Notes; 2018 Oct; 11(1):717. PubMed ID: 30305145
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High susceptibility for enterovirus infection and virus excretion features in Tunisian patients with primary immunodeficiencies.
    Driss N; Ben-Mustapha I; Mellouli F; Ben Yahia A; Touzi H; Bejaoui M; Ben Ghorbel M; Triki H; Barbouche MR
    Clin Vaccine Immunol; 2012 Oct; 19(10):1684-9. PubMed ID: 22914367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening for long-term poliovirus excretion among children with primary immunodeficiency disorders: preparation for the polio posteradication era in Bangladesh.
    Sazzad HM; Rainey JJ; Kahn AL; Mach O; Liyanage JB; Alam AN; Kawser CA; Hossain A; Sutter R; Luby SP
    J Infect Dis; 2014 Nov; 210 Suppl 1():S373-9. PubMed ID: 25316858
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The feasibility of identifying children with primary immunodeficiency disorders: preparation for the polio post-eradication era in Bangladesh.
    Sazzad HM; Rainey JJ; Mach O; Sutter R; Diordista S; Kawser CA; Mobarak R; Alam D; Chowdhury MA; Hossain MJ; Hasan AS; Luby SP
    Vaccine; 2012 Aug; 30(36):5396-400. PubMed ID: 22728220
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Eradicating polio: how the world's pediatricians can help stop this crippling illness forever.
    Orenstein WA;
    Pediatrics; 2015 Jan; 135(1):196-202. PubMed ID: 25548328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Update on vaccine-derived polioviruses.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2006 Oct; 55(40):1093-7. PubMed ID: 17035927
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Molecular Evolution of Type 2 Vaccine-Derived Polioviruses in Individuals with Primary Immunodeficiency Diseases.
    Kitamura K; Shimizu H
    Viruses; 2021 Jul; 13(7):. PubMed ID: 34372613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaccine poliovirus shedding and immune response to oral polio vaccine in HIV-infected and -uninfected Zimbabwean infants.
    Troy SB; Musingwini G; Halpern MS; Huang C; Stranix-Chibanda L; Kouiavskaia D; Shetty AK; Chumakov K; Nathoo K; Maldonado YA
    J Infect Dis; 2013 Aug; 208(4):672-8. PubMed ID: 23661792
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of a Highly Divergent Type 3 Vaccine-Derived Poliovirus in a Child with a Severe Primary Immunodeficiency Disorder - Chongqing, China, 2022.
    Yao N; Liu Y; Xu JW; Wang Q; Yin ZD; Wen N; Yang H; Rodewald LE; Zhang ZY
    MMWR Morb Mortal Wkly Rep; 2022 Sep; 71(36):1148-1150. PubMed ID: 36074738
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.